Clinical Trial Update: Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating focused ultrasound to disrupt the blood-brain barrier in high-grade glioma patients undergoing standard chemotherapy. Rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: GBM, Glioblastoma Multiforme (GBM) | Phase 1 | Status: RECRUITING